Law360 Canada ( December 2, 2021, 6:10 AM EST) -- Appeal by Canada RNA Biochemical from a judgment of the Federal Court that dismissed its application for judicial review. The Minister of Health refused to grant a Natural Health Product licence to the appellant for oral lumbrokinase capsules, branded Boluoke, to improve circulation. The Minister concluded the evidence submitted was insufficient to support the safe use of lumbrokinase. The Minister, who consulted an external hematologist, emphasized the risk of internal bleeding could not be properly monitored in circumstances where the product was sold over the counter. The Federal Court concluded the refusal to grant the appellant a licence was reasonable....